Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the

F Irsel Tezer1, Farid Xasiyev1, Figen Soylemezoglu2

  • 1Hacettepe University, Faculty of Medicine, Dept. of Neurology, Ankara, Turkey.

Epilepsy Research
|August 26, 2016
PubMed

Insights

Hippocampal sclerosis (HS) types 2 and 3 in mesial temporal lobe epilepsy (MTLE) are linked to a higher incidence of generalized tonic-clonic seizures and a family history of epilepsy. These findings aid in understanding HS epileptogenicity and prognosis.

Area of Science:

  • Neurology
  • Epileptology
  • Pathology

Background:

  • Hippocampal sclerosis (HS) is a common pathology in mesial temporal lobe epilepsy (MTLE).
  • The 2013 International League Against Epilepsy (ILAE) classification categorizes HS into three types, plus 'gliosis only'.
  • Detailed associations between clinical/electrophysiological findings and HS types are not well-established.

Purpose of the Study:

  • To investigate the correlation between HS ILAE types and clinical/EEG findings in MTLE patients with HS.
  • To explore potential differences in clinical features and outcomes based on HS classification.

Main Methods:

  • Retrospective analysis of 48 MTLE patients who underwent temporal lobectomy with amygdalohippocampectomy.
  • Classification of patients into five groups: HS ILAE types 1, 2, 3, focal cortical dysplasia type IIIa (FCD type IIIa), or gliosis/no HS.
  • Correlation analysis of HS types with epilepsy duration, onset age, semiological findings, EEG data, family history, and seizure history.

Main Results:

  • No association was found between HS types and epilepsy duration, onset age, semiological findings, or EEG characteristics.
  • Family history of epilepsy and severe generalized tonic-clonic seizures (SGTCSs) were more frequent in patients with HS types 2 and 3.
  • Status epilepticus was more frequent in patients with HS-FCD type IIIa.

Conclusions:

  • HS types 2 and 3 are associated with a higher frequency of SGTCSs, status epilepticus, and a family history of epilepsy.
  • These distinctions may offer insights into the epileptogenicity and prognosis of different HS subtypes.
  • Further research can refine understanding of HS classification's clinical relevance.
Abstract

Related Concept Videos